Objectives: To identify and assess the effects of general practitioner and patient characteristics on global adherence to pharmacotherapeutic guidelines. Methods: In a cross-sectional study in the northern Netherlands, a two-level multilevel model was applied to patients (n = 269,067) in 190 practices with a total of 251 general practitioners. The dependent variable was the global adherence to pharmacotherapeutic guidelines as a measure of good prescribing in a general practice setting. Results: The mean global adherence was 82%. Two general practice variables, organization form and degree of urbanization influenced the global adherence, whereas all patient variables (age and gender) and the patient-related prescription characteristics (costs, volume, different ATC-codes) were significant predictors for the global adherence. The total explained variance was 28%. Conclusions: Patient characteristics have a greater influence on prescribing behavior than general practitioner characteristics.
In 1987, the World Health Organization (WHO) published a statement about good prescribing: "rational use of drugs requires that patients receive medications appropriate to their clinical needs, in doses that meet their own individual requirements, for an adequate period of time and at the lowest costs to the community" (24) . To amplify this statement, Barber described good prescribing as based on four criteria: maximize effectiveness, minimize risks, minimize costs, and respect for the patient's choices (3).
It is not easy for general practitioners (GPs) to comply with the above criteria, as the prescribing of drugs is a process affected by many factors. Kamps et al. chose adherence to a set of regional pharmacotherapeutic guidelines as a criterion for good prescribing (15) . They evaluated the adherence of sixteen GPs to the third edition of the Groningen formulary (GFIII) (1), taking into account two forms of adherence: global adherence, defined as the prescribing of a drug mentioned in the formulary; and specific adherence, defined as the prescribing of a drug mentioned in the formulary for which its indication is also mentioned in the formulary. The global adherence varied from 76 to 89% and the specific adherence from 55 to 71%. GPs with a high percentage of adherence were considered to be appropriate prescribers.
Factors predicting good prescribing can be divided into patient-related and general practitioner-related. Straand and Rokstad estimated the incidence of inappropriate prescribing for the elderly at 13.5% (22) . By using a multilevel analysis, Houghton concluded that
We thank the health care insurance organization (Regionaal Ziekenfonds Groningen [RZG] ) for supplying the data set. We also thank Eddie Bruin from the health care insurance organization for his assistance with data collection and Tom Snijders for data analysis and statistical advice. patients over 65 years of age used more prescriptions and, therefore, indirectly contributed to higher prescribing costs. Independent of age, women were given more prescriptions by their GPs than men (14) . Elderly people living in a nursing home received more prescriptions than those living at home (2) . With respect to the identified GP-related factors, funded and training practices are associated with prescribing fewer and less expensive drugs (14) . The level of knowledge of Canadian general practitioners and the financial demographics of the practice (government funded versus fee for service general practitioners) are examples of GP-related factors that contribute to the inappropriateness of prescribing behavior (16) . Variation in GP prescribing and the associated costs can partially be explained by the number of partners in the practice, the level of poverty in the practice population, and the preceptorship status of practice (23) .
A review of 62 studies by Buetow et al. tried to reveal circumstantial evidence for inappropriate prescribing by GPs in the UK (5). The conclusion of this study was that "although inappropriate prescribing occurred, the scale of the problem is unknown, because of limitations associated with selection of a standard, publication bias and uncertainty about the context of prescribing decisions." However, prescribing indicators applicable to individual patients can yield evidence of prescribing appropriateness.
The effect of feedback on prescribing habits turns out to be variable (10;18;20) , also when computers are used to provide information about drug prescribing and the associated costs (19;20) . National guidelines may enhance the quality of prescribing. In the Netherlands, GPs adhered to 61% of prescribing advices in the national guidelines of the Dutch College of General Practitioners (13) .
In the present research, we studied the contribution of practice and patient characteristics on global adherence to pharmacotherapeutic guidelines as a measure of good prescribing in a general practice setting. Moreover, we assessed the interpractice variation.
METHOD
In the Netherlands, community pharmacists provide medications to the patients according to the prescription of the GP. All prescriptions for patients with obligatory public health insurance, approximately 60% of all patients, were registered. The data were collected over the period January to December of 1997 in the province of Groningen in the north of The Netherlands. At that time, the population of Groningen was 558,000 (3.6% of the Dutch population). The database included 269,000 patients with approximately 3.2 million prescriptions.
General Practices
The total database included 251 GPs from 190 general practices. The following variables were recorded: the number of male and female patients; the gender and the mean age of the GP; the localization of the practice (rural if the population density is less than 1,500 addresses per square kilometer or urban if the population density of the environment is 1,500 addresses per square kilometer or more) (8) , the number of GPs per practice, the type of practice (solo practice or group practice). For each patient, age and gender were recorded. For each prescription, the Anatomical Therapeutic Classification-code (ATC), the Defined Daily Dose (DDD), and the costs were registered (in Euro). The number of different ATC's was considered as a proxy for multiple morbidity and severity of morbidity. An ATC-code was missing in 6% of the 3.2 million prescriptions.
Global adherence was defined as a prescribing of a drug that is mentioned in the Groningen Formulary (GFIII). The GFIII appeared for the first time in 1991 and was formulated based on a consensus reached by three GPs, two specialists and seven pharmacists (1).
The third edition of the Groningen Formulary, published in 1995, was used for the present study. It contained 251 medications for 186 health problems. Two of the GPs participating in the present study also participated in the development of the GFIII. It was not possible to identify these two GPs because the names of the GPs were eliminated to make them anonymous. The GFIII was distributed to all GPs in the region, free of charge, by the public health insurance organization.
Analysis
Because the database of 3.2 million prescriptions was too large to analyze, a stratified random sample of 12.5% of the patients per general practice was used. All the prescriptions for each patient in the sample were included, and aggregated to patient-level. The influence of the different factors and the interpractice variation were analyzed with multilevel models. The dependent variable was the percentage global adherence per patient. The multilevel modeling technique from the SAS statistical package (Proc Mixed) and Mlwin program from Goldstein were used to analyze the data (11;17) .
Two blocks of variables were used: practice-related variables and patient-related variables. With regard to the patient-related variables, it should be mentioned that there are two different kinds of variables: variables "directly related" to the patient (e.g., age), and variables "aggregated" to the patient level (e.g., cost of the prescription aggregated to mean costs). We used a two level model: the first level being the patient level, and the second level being the practice level. To obtain a meaningful interpretation of the estimated parameters, the data were centered on their grand mean. The dummy variables (with values 0 or 1) in this model are the practice characteristics, viz. type and location, and the patient characteristic, viz. gender. The value 1 refers to solo practice, urban, and male patient, respectively.
The following statistics were used: (1) Intraclass correlation coefficient (ICC). This statistic measures the proportion of the variance of the global adherence between different practices (4;21). (2) Explained variance. (3) Log-likelihood, which is useful for comparing the goodness of fit of different models. If the ratio between parameter estimate and standard error is larger then 1.96, the parameter estimate under consideration is significant.
Several models were used. First, the baseline (or null) model (Model 0) concerning the influence of the variation on global adherence was fitted. By adding of two blocks of variables, the practice characteristics (Models A and B), and the patient characteristics (Model C), the influence of these characteristics was assessed. In Model D, only the significant practice and patients characteristics were assessed.
To investigate whether interdependent relations existed between different variables, interactions between two variables were studied. In Model D, a cross-level interaction between two variables of different levels was studied: age of the patient and morbidity.
In the models described above, the so-called fixed effects were described. The objective of fixed effects is to compare means of treatment groups or populations, whereas random effects are computed when the objective is to determine sources of variability. The latter were studied to assess which patient characteristics are responsible for the interpractice variation (Model E). To determine which variables are the most important, the coefficients of the final model were standardized (21) .
RESULTS
The mean age of practitioners was 48.2 years (SD 6.0), and 91% were men (SD 24.2). The number of solo practices was 149 (78.4%), whereas 30 (15.8%) were duo-practices and the remaining 11 (5.8%) were group practices (3-6 GPs). Sixty percent of the practices were situated in an urban area. The mean number of male patients per practice was 682 (SD 209.3); of female patients, 749 (SD 208.1). Table 1 shows that the sample turned out to be a good representation of the total database with regard to patient characteristics (age and gender), prescription characteristics (costs, DDD, number of different prescriptions per patient), and global adherence. Table 2 shows the parameter estimates and their standard errors of the GP-and patient characteristics in the different models (Models 0, A, B,C,D). In Model 0, the maximum likelihood estimate for the global adherence is 82.44% (standard error 0.33) ( Table 2 ). This mean of approximately 82% should be interpreted as the expected value of the global adherence for a random patient in a randomly drawn practice. The maximum likelihood estimate of the variance component at patient level was 682.9 (standard error 5.3) and the estimated variability of means for the different practices was 15.4 (standard error 2.1). These variance components indicate that most of the variation of the global adherence was at patient level. The ICC of 0.02, indicates that 2% of the variance in global adherence existed between practices.
In Model A, in which the practice characteristics were added, the mean global adherence (82%) did not change. The variables, organization form (solo versus group practice) and urbanization degree (rural vs urban), were the only significant practice characteristics revealed. The interaction term (organization form by urbanization degree) was not significant. In Table 2 , Model 0 yields a deviance of 308,373.6, whereas Model A gives a deviance of 308,345.7. The difference 27.9 is significant as calculated with a chi-squared distribution test with seven degrees of freedom (d.f.).
In Model B, only the significant practice characteristics (type of practice and location of the practice) were given. In Model C, the patient characteristics were analyzed. The age and gender of the patient were both significant factors, and their interaction term, age by gender, was also significant. Furthermore, the patient-related prescription characteristics (costs, volume, and different ATC-codes) were all significant. In this model, the crosslevel interaction term, age of the patient by different ATC-codes, was also significant. The deviance difference between Model 0 and Model C is 1,405.4 (significant in a chi-squared distribution with seven d.f.).
In Figure 1 , the relation between global adherence and age for men and women is illustrated. From this figure, it can be seen that there is an important difference between the genders, particularly in the age group 15-35 years. We assumed that the effect was mainly due to the contraceptive pill. Figure 2 shows that the gender difference for all ATCs with exclusion of the contraceptive pill codes (G03AA, G03AB, G03FA, G03FB, and G03HB) virtually disappeared in the age group 15-35 years. This finding clearly illustrates the effect of the contraceptive pill.
With respect to Model D, the total explained variance for all significant factors that influence global adherence was 28%. The practice characteristics explain 11%, and the patient characteristics explain 15%. The rest, 2% is due to the correlation between practice-and patient characteristics. In Model D, two of the six practice characteristics (type of practice and location of the practice ) and all patient characteristics (including two interactions) are involved as fixed effects.
Model E (Table 3) indicates the random effects of the patient characteristics by which differences among general practices of these variables were revealed. These variables are age, gender, and mean costs of the patient. After standardizing (21) the coefficient of each variable, the ranking is as follows: age of the patient, mean costs, the mean volume (DDD), different ATCs, type of practice, location of the practice, and finally gender, and the interaction age by gender.
DISCUSSION
The present study shows that the degree of adherence to guidelines was influenced by two practice characteristics (solo or group practice and rural or urban location) and all patient characteristics (age, gender, mean costs, mean volume, and different ATC). The study does have limitations. First, the population included only patients with obligatory health insurance. Second, only the adherence to medications-advices could be studied, as the database did not include indications for prescribing of these medication. We assume that studies adding prescription indications might result in superior models (5;6;15) . In all the models studied, a global adherence of 82% was found, which is comparable to the results of others (3;12;15); 11% of the 28% explained variance was due to the characteristics of the general practices, viz. type of practice and location of the practice. Concerning differences in global adherence the interpatient variation is much greater than the interpractice variation. Other variables that may account for the remaining unexplained variance are hospital initiated prescribing, the prescription history of the patient and patient insistence (6) . Therefore, the development of models that takes the patient's perspective into account is necessary.
In common with the study of Davies and Gribben, in which the practice variable "small practice" was one of the significant predictors, we found a significant contribution of the organization form (7) . All the patient characteristics influence global adherence, including the interaction age by gender and the cross-level interaction age by different ATCs. But it is possible to reduce the interpractice variation of gender and age to three kinds of practices. With relation to the random effect of gender, there are (1) practices where men and women contribute in the same amount to the compliance, (2) practices in which women contribute more, and (3) some practices in which men contribute more to the compliance. With relation to the random effect of age said it appears that (1) in some practices the compliance increases, (2) in other practices the compliance decreases, and (3) in other practices the compliance stays the same with increasing age. With regard to the second kind, multiple morbidity in the elderly is probably a contributing factor to this trend of the negative relation between the age of the patient and the global adherence. In a patient with multiple morbidity, GPs more often prescribe medications not advised in the formulary. This explanation also applies to the negative relation that exists between global adherence and the number of different ATCs. Usually, patients who are seriously ill or who suffer from more diseases receive prescriptions for several medications, including an increasing number of second choice medications, which are not mentioned in the formulary.
The total number of prescriptions in a practice correlates positively with global adherence. This finding could be caused by the increased number of repeat prescriptions (9) . As the cost increased, adherence decreased. This finding is in agreement with one of Barber's criteria, as increasing adherence, therefore, would tend to minimize costs (3). The negative relation between global adherence and cost for the fixed effects suggests that, in general, when global adherence increases, the mean cost decreases. The random effect of mean costs points to the fact that there are two kinds of general practices: in some practices the mean costs increases, while the compliance decreases, and other practices the compliance stayed the same. All these significant characteristics of patient and practice merit further investigation to improve the quality of prescribing in general practice.
POLICY IMPLICATIONS
In this study, more insights into the factors on practice and patient level related to good prescribing, measured by global adherence, is given. Good prescribing is an important issue for the quality of care of patients, for adequate performance of prescribers and for costs. Because the general practitioners use more and more information systems, that are linked to electronic prescribing systems, the chance of good prescribing will increase in the near future. Both on practice-and on patient level, we found factors that are important to take into account during the development of programs for good prescribing. Factors on patient level (age and mean costs of the patient) were more important than factors on practice level (type and location of the practice). By developing programs for good prescribing, the rural practice will have to be more motivated than the urban practice to reach the same results. Motivation for good prescribing is also more important in the case of soloists than in group practices. Because the age of the patient was found to be the most important factor, general practitioners should be made especially aware of their prescribing patterns for their elderly patients. If electronic prescribing systems are meant to stimulate good prescribing, the significant variables found in this study can be used for the evaluation of these systems.
